Skip to content

Relivion

by Neurolief, Ltd. 2 variants

510(k) K203419

Relivion is a medical device (FDA Class II; FDA product code PCC, Stimulator, Nerve, Electrical, Transcutaneous, For Migraine) made by Neurolief, Ltd., cleared under FDA 510(k) K203419 on 16 Feb 2021, active as of 10 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 10 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 10 Oct 2026.

Regulatory status

as of registry sync 10 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK203419 Date16 Feb 2021ClearedStatusActive

Official records

From the FDA record

Received by the FDA
19 Nov 2020
FDA decision
16 Feb 2021 (Substantially Equivalent)
FDA review time
89 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K203419 (openFDA), as read on 10 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
PCC
FDA applicant
Neurolief , Ltd.
Device class
Class II
Regulation
21 CFR Part 882.5891
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code PCC (Stimulator, Nerve, Electrical, Transcutaneous, For Migraine).

Other devices from Neurolief, Ltd.

See all devices from Neurolief, Ltd. →